Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery | Last updated: July 1, 2026
Key Takeaways
- A personalized semaglutide program at Mirror Plastic Surgery starts with labs, custom dosing, and close medical oversight, not a generic prescription.
- Ellie Pranckevicius, FNP-BC, leads Mirror’s concierge peptide therapies, combining ICU-level clinical training with advanced aesthetic experience.
- GLP-3R agonists may cause fewer GI side effects and support better muscle preservation than traditional semaglutide, although individual responses differ.1
- Local concierge oversight provides batch-tested sourcing, transparent compounding standards, and direct access to your practitioner, which most online programs do not offer.
- Patients who want a medically supervised semaglutide or GLP-3R program can schedule a consultation at Mirror Plastic Surgery to review labs and design a tailored plan.
Ellie Pranckevicius, FNP-BC: Your Concierge Peptide Specialist
Ellie Pranckevicius, FNP-BC, is a board-certified Family Nurse Practitioner who leads peptide therapies and non-surgical aesthetics at Mirror Plastic Surgery. She holds a Bachelor’s in Health Science from Boston University, completed an aesthetics licensure program, and earned both her Bachelor’s and Master’s in Nursing from the University of South Florida. Her four years in the Neuroscience ICU at Tampa General Hospital built a deep command of physiology, metabolic health, and complex patient management that now shapes her approach to GLP-1 and GLP-3R programs. That clinical foundation, combined with her earlier work at a high-end Boston medical spa, gives Ellie a rare dual perspective. She understands the aesthetic results patients want and the clinical science required to reach them safely.
Semaglutide vs GLP-3R Agonists: How These Peptides Work
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist first developed for type 2 diabetes and later approved for chronic weight management. It mimics the GLP-1 hormone, slows gastric emptying, reduces appetite, and improves insulin sensitivity. FDA-approved branded formulations, both injectable and oral, are produced under strict pharmaceutical standards. Compounded semaglutide, prepared by licensed compounding pharmacies, is not FDA-approved as a finished drug product, so quality and potency depend entirely on the sourcing and testing practices of the pharmacy used.
GLP-3R agonists represent a newer generation of peptide therapy. GLP-1 agents act on a single receptor pathway, while GLP-3R formulations are reported to influence broader metabolic signaling. Early data suggest a more favorable gastrointestinal side-effect profile, a lower likelihood of lean muscle loss, and potential use in insulin resistance, cardiovascular risk factors, and weight management.1 Titration, which means gradually increasing the dose over weeks or months, applies to both classes. This stepwise approach helps limit side effects and match the therapeutic level to each patient’s tolerance.
Contraindications for GLP-1 class agents include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and active pancreatitis. A thorough medical history review is required before any program begins. This screening requirement explains why Mirror Plastic Surgery’s clinical workflow starts with a comprehensive intake process before any prescription is written.
Inside Mirror’s Medically Supervised Dosing Program in Tampa and St. Petersburg
At Mirror Plastic Surgery, the clinical workflow for a semaglutide or GLP-3R program follows a structured sequence that individualizes every element of care.
Intake and history review: A 30–60 minute consultation with Ellie covers full medical history, current medications, prior weight-management attempts, and specific goals. Contraindications are screened before any protocol is discussed.
Baseline laboratory panel: For weight management programs, existing labs are reviewed or new labs are ordered. The panel typically includes:
- Thyroid function (TSH, free T3, free T4)
- Comprehensive metabolic panel (liver and kidney function, electrolytes, glucose)
- Lipid panel
- Fasting insulin and HbA1c (diabetes markers)
- Hormone panels (as clinically indicated)
Individualized starting dose and titration schedule: The starting dose and escalation timeline are set based on lab findings, body composition, and tolerance history. Mirror avoids generic protocols that treat every patient the same.
Monitoring cadence: Follow-up appointments track weight, body composition changes, side effects, and lab markers. Dose adjustments are made in response to real data rather than a fixed calendar.
Maintenance considerations: Long-term planning addresses the reality that GLP-1 class agents usually require continued use to sustain results. Lifestyle measures such as nutrition, activity, and sleep remain central throughout treatment.
Concierge access: Ellie remains available via direct text between visits for questions, side-effect management, and refill requests. This level of access is rarely available through high-volume telehealth platforms.
Comparing Traditional Semaglutide and GLP-3R: Side Effects, Muscle, and Uses
| Agent | GI Side-Effect Profile | Muscle-Preservation Data | Broader Indications |
|---|---|---|---|
| Semaglutide (GLP-1) | Moderate to significant nausea, vomiting, and constipation often occur during dose escalation, and symptoms usually improve with careful titration. | Lean mass loss is a documented concern, so resistance training and adequate protein intake are strongly recommended.1 | Type 2 diabetes, chronic weight management, and cardiovascular risk reduction are current FDA-approved indications. |
| GLP-3R Agonist (compounded) | Reported to produce fewer and milder GI symptoms than GLP-1 agents, although individual response varies.1 | Emerging reports suggest a more favorable muscle-preservation profile compared to GLP-1, and clinical data are still accumulating.1 | Weight management, insulin resistance, and cardiovascular risk factors are current areas of use, with broader metabolic indications under investigation. |
All descriptors above are qualitative. No head-to-head trial data are cited because no peer-reviewed comparative studies were available at the time of publication. Individual results vary.
Book an appointment with Ellie to review which agent aligns with your lab results, health history, and goals.
Why Local Concierge Oversight Beats One-Size-Fits-All Online Programs
The rapid growth of compounded GLP-1 prescriptions has drawn significant regulatory attention. The FDA has issued guidance on when compounded semaglutide is permissible, and enforcement has shifted as branded supply constraints have eased. For patients in Tampa and St. Petersburg, this environment makes sourcing transparency and hands-on oversight essential when choosing any program.
Five connected factors determine whether a local or online program can deliver safe, effective results.
Batch testing establishes baseline quality. Reputable compounding pharmacies provide certificates of analysis confirming potency, purity, and sterility for each batch, and Mirror Plastic Surgery sources only from pharmacies that meet this standard. Sourcing transparency builds on that foundation. Patients should be able to ask where their compound originates and receive a clear, direct answer.
Supervision depth then becomes the next layer. A program that includes labs, individualized titration, and direct practitioner access differs fundamentally from one that issues a prescription after a brief online questionnaire. This depth of supervision matters because of individual response variability. GLP-1 and GLP-3R agents can produce very different outcomes across patients, and ongoing monitoring is how problems are caught early and dosing is adjusted.
Lifestyle integration completes the picture. Even with perfect sourcing and supervision, peptide therapy alone rarely creates lasting change. Nutrition, resistance training, and sleep quality all influence outcomes and work best with structured guidance alongside the medication protocol.
Risks, Limits, and Misconceptions Around GLP-1 Programs
Documented risks and side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite, which tend to be most pronounced during dose escalation. Lean muscle mass loss is a real concern when sustained caloric restriction is combined with GLP-1 use. Rare but serious risks include pancreatitis and, for those with relevant personal or family history, thyroid C-cell tumors.
Contraindications include the medullary thyroid carcinoma and MEN2 history noted earlier, along with active gallbladder disease and certain gastrointestinal conditions. Medication interactions also require careful review before starting any program.
Regulatory status: As noted above, compounded semaglutide and GLP-3R formulations are not FDA-approved finished drug products. Quality therefore depends on the compounding pharmacy’s standards and the oversight provided by the prescribing practitioner.
Common misconceptions:
- “All GLP-1 programs are the same.” They differ widely. Sourcing quality, titration protocols, monitoring frequency, and practitioner access can vary dramatically between providers.
- “Peptides are only for weight loss.” GLP-1 and GLP-3R agents can address insulin resistance, cardiovascular risk factors, and broader metabolic health. Mirror’s peptide program also extends to inflammation, recovery, anti-aging, and neurological health.
- “Stopping treatment means permanent results.” Weight regain is well documented after GLP-1 discontinuation without a maintenance strategy.1 Long-term planning should begin at the start of treatment.
Frequently Asked Questions
What makes a semaglutide program “personalized” versus a standard prescription?
A personalized program starts with a full medical history review and a baseline laboratory panel that covers thyroid, metabolic, hepatic, renal, and hormone markers. The starting dose, titration schedule, and monitoring frequency are then set based on those individual findings rather than a fixed template. Ongoing adjustments are made in response to real patient data, including side effects, lab changes, and body composition progress.
Is compounded semaglutide safe to use?
Compounded semaglutide is not an FDA-approved finished drug product, as discussed earlier. Its safety depends on the quality standards of the compounding pharmacy, including batch testing for potency and sterility, and on the medical supervision of the prescribing practitioner. Obtaining compounded semaglutide without a prescription, from unverified online sources, or without medical oversight carries significant risks related to unknown purity, incorrect dosing, and undetected contraindications.
How is GLP-3R different from semaglutide, and is it available in St. Petersburg?
GLP-3R agonists are a newer class of compounded peptide that engage broader metabolic receptor pathways than GLP-1 agents like semaglutide. They are reported to produce fewer gastrointestinal side effects and a more favorable muscle-preservation profile, although clinical data are still developing. Mirror Plastic Surgery offers GLP-3R compounding as part of its concierge peptide program in St. Petersburg, and Ellie Pranckevicius determines candidacy based on individual labs and health history.
What lab tests are required before starting a semaglutide program?
The baseline panel described in the program overview establishes thyroid, metabolic, hepatic, renal, and hormone markers. These values guide the starting dose, help identify contraindications, and create a baseline for tracking progress and safety over time.
Can I access Mirror Plastic Surgery’s semaglutide program remotely if I am not in Tampa?
Yes. Mirror Plastic Surgery can conduct consultations, issue prescriptions, and coordinate shipping remotely across the United States, including Hawaii and Alaska. Patients in the Tampa Bay and St. Petersburg area can also choose in-person consultations at the practice’s location at 780 4th Ave S, St. Petersburg, FL 33701.
Choosing Personalized Semaglutide Care in Tampa Bay
For Tampa Bay professionals who have already tried diet and exercise without lasting results, a medically supervised semaglutide or GLP-3R program offers a structured, evidence-informed path forward when built on the right foundation.1 That foundation includes comprehensive labs, individualized titration, batch-tested sourcing, and a practitioner who remains accessible between appointments and willing to adjust the protocol as your data evolve. Mirror Plastic Surgery’s concierge model, led by Ellie Pranckevicius, FNP-BC, is designed to deliver that level of oversight in a market where many alternatives are high-volume telehealth platforms or unsupervised online sources.
Disclaimer: Results from semaglutide and GLP-3R programs vary by individual based on genetics, lifestyle, adherence, and baseline health status. Compounded semaglutide and GLP-3R formulations are not FDA-approved finished drug products. All peptide therapies at Mirror Plastic Surgery are provided under the supervision of a licensed medical professional and require a clinical consultation prior to initiation. Nothing in this article constitutes medical advice or a guarantee of outcomes.
Book an appointment with Ellie to begin with a comprehensive consultation and lab review tailored to your health profile and goals.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
